Evolus, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
EOLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
520 Newport Center Drive, Suite 1200, Newport Beach, CA

Insiders trading volume in the past year

Evolus, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alphaeon 1 LLC 10%+ Owner $35.4M Feb 17, 2023
Medytox Inc. Former 10% Owner $25.4M Oct 16, 2023
David Moatazedi President and Chief Executive Officer, Director $8.38M -$7.77M -48.1% Mar 27, 2025
Simone Blank Director $6.08M Mar 7, 2025
Rui Avelar Officer $5.06M -$438K -7.96% Mar 18, 2025
Vikram Malik Director $2.76M -$459K -14.3% Mar 7, 2025
Sandra Beaver Chief Financial Officer $2.69M -$216K -7.45% Mar 18, 2025
Tomoko Yamagishi-Dressler Chief Marketing Officer $1.46M -$149K -9.27% Mar 18, 2025
Lauren P. Silvernail Chief Financial Officer and Executive Vice President, Corporate Development $1.38M May 17, 2022
Crystal Muilenburg Chief Marketing Officer $1.31M Mar 8, 2022
Robert Hayman Director $857K Feb 7, 2024
Brady Stewart Director $636K Mar 7, 2025
Peter C. Farrell Director $517K Jan 27, 2023
David N. Gill Director $448K -$131K -22.6% Mar 7, 2025
Karah Parschauer Director $418K -$167K -28.6% Mar 12, 2025
Albert G. White III Director $330K Mar 7, 2025

Recent Insider Transactions by Companies or Individuals for Evolus, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.